Skip to main content
SpringerLink
Log in

Cardiac Phenotype–Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Cardiac involvement of Duchenne and Becker muscular dystrophies (DMD/BMD) is the most common cause of fatal outcomes. It is still unclear whether some DMD/BMD gene mutations might be predictive of cardiac involvement. In this study, we provide a comprehensive overview on genotypes of cardiac disease in DMD/BMD. We systematically searched the PubMed/Medline, EMBASE and Cochrane electronic databases. Search results were filtered to include only human studies, English language and all dates up to August 2019. We summarized and extensively reviewed all studies that passed the selection criteria and performed a meta-analysis on key genotype parameters of cardiac disease in DMD/BMD. Of 3450 articles scanned, we included 18 studies from 9 regions in the meta-analysis. The pooled studies included 2661 DMD/BMD patients and 1324 DMD/BMD patients with cardiac disease. The most common mutation type was exon deletion, with a pooled frequency of 90% (P < 0.01). In DMD/BMD patients with cardiac dysfunction, a higher frequency of involvement of exons 45 and 46 was found in DMD/BMD patients with cardiac dysfunction. This might be predictive of cardiac involvement in patients with DMD/BMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731

    CAS  PubMed  Google Scholar 

  2. Emery AE (1991) Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul Disord Nmd 1:19

    CAS  PubMed  Google Scholar 

  3. Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE (2009) Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 80:320

    CAS  PubMed  Google Scholar 

  4. Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H, Hamada S, Minami R (2011) Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscul Disorders Nmd 21:47

    Google Scholar 

  5. Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002 Naarden, the Netherlands. Neuromuscul Disord 2003(13):166

    Google Scholar 

  6. Mcnally EM, Kaltman JR, Woodrow Benson D, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590

    PubMed  PubMed Central  Google Scholar 

  7. Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51:70

    PubMed  Google Scholar 

  8. Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533

    CAS  PubMed  Google Scholar 

  9. Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329

    CAS  PubMed  Google Scholar 

  10. Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla VS (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94:3168

    CAS  PubMed  Google Scholar 

  11. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE (1994) Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72:246

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Berko BA, Swift M (1987) X-linked dilated cardiomyopathy. New Engl J Med 330:368

    Google Scholar 

  13. Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, Weiss RB, Flanigan KM, Mendell JR, Montanaro F (2009) Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2:544

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Nigro G, Comi LI, Politano L, Bain RJI (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271

    CAS  PubMed  Google Scholar 

  15. Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, Mccarthy B, Taylor MD (2015) Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 14:153

    CAS  PubMed  Google Scholar 

  16. Allen HD, Flanigan KM, Thrush PT, Dvorchik I, Yin H, Canter C, Connolly AM, Parrish M, Mcdonald CM, Braunlin E (2013) A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy. PLoS Currents 5:2c

    Google Scholar 

  17. Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD (2012) Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol 110:98

    CAS  PubMed  Google Scholar 

  18. Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Ji MS, Rhee JH, Park YM, Ma DW, Chung H (2013) Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients. Int J Cardiol 167:1990

    PubMed  Google Scholar 

  19. Rhodes J, Margossian RB, Colan S, Jenkins K, Geva T, Powell A (2008) Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 29:343

    CAS  PubMed  Google Scholar 

  20. Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA (2007) Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 98:825

    Google Scholar 

  21. Markham LW, Kinnett K, Wong BL, Woodrow BD, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 18:365

    PubMed  Google Scholar 

  22. Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH (2005) Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 26:768

    CAS  PubMed  Google Scholar 

  23. Barber BJ, Andrews JG, Zhenqiang L, West NA, John Meaney F, Price ET, Ashley G, Sheehan DW, Shree P, Michele Y (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr-US 163:1080

    CAS  Google Scholar 

  24. Houde S, Filiatrault M, Fournier A, Dubé J, D'Arcy S, Bérubé D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38:200

    PubMed  Google Scholar 

  25. Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, Khairy P (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948

    PubMed  Google Scholar 

  26. Ogata H, Ishikawa Y, Ishikawa Y, Minami R (2009) Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 53:316

    Google Scholar 

  27. Herrera Enríquez MC (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596

    Google Scholar 

  28. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799

    PubMed  Google Scholar 

  29. Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in Duchenne muscular dystrophy and genotype. Am J Cardiol 114:284

    PubMed  PubMed Central  Google Scholar 

  30. Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Rev Española De Nutr Hum Y Dietética 18:123

    Google Scholar 

  31. Cirino RHD, Scola RH, Ducci RDP, Wermelinger ACC, Kay CSK, Lorenzoni PJ, Werneck LC, Carmes ER, Da CCLP (2018) Predictors of early left ventricular systolic dysfunction in Duchenne muscular dystrophy patients. Muscle Nerve 58:84

    CAS  Google Scholar 

  32. Gambetta K, Wittlieb-Weber C, Bock M, Villa C, Johnson J, Lal A, Schumacher K, Law S, Deshpande S, West S, Friedland-Little J, Lytrivi I, Butts R, Cunningham C, Knecht KR, McCullough M (2018) Impact of genotype on boys with Duchenne muscular dystrophy. J Heart Lung Transpl 37:S122

    Google Scholar 

  33. Martins E, Silva-Cardoso J, Silveira F, Nadais G, Rocha GF (2005) Left ventricular function in adults with muscular dystrophies: genotype-phenotype correlations. Rev Port Cardiol 24:23

    PubMed  Google Scholar 

  34. Nakamura K, Goto K, Ishikawa T, Shimazaki R, Matsubara E (2017) Genotype of early death due to cardiac failure in Duchenne muscular dystrophy. J Neurol Sci 381:823

    Google Scholar 

  35. Del GD, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM (2008) Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 29:1100

    Google Scholar 

  36. Aartsma-Rus A, Ginjaar IB, Bushby K (2016) The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 53:145

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Howard MT, Day JW, McDonald C, Nicolas A, Le Rumeur E, Weiss RB, Flanigan KM (2015) Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol 77:668

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane H (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596

    CAS  PubMed  Google Scholar 

  39. Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M (2010) Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 49:1357

    CAS  PubMed  Google Scholar 

  40. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177

    CAS  PubMed  Google Scholar 

  41. Kolski H, Spurney C, Morgenroth PL, Shimizu R, Clemens RP (2014) Cooperative international neuromuscular research group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50(2):250–256

    PubMed  PubMed Central  Google Scholar 

  42. Nigro G, Politano L, Nigro V, Petretta VR, Comi LI (1994) Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 4:371

    CAS  PubMed  Google Scholar 

  43. Freund AA, Scola RH, Arndt RC, Lorenzoni PJ, Kay CK, Werneck LC (2007) Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq Neuropsiquiatr 65:73

    PubMed  Google Scholar 

  44. Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Therapy J Am Soc Gene Therapy 17:253

    CAS  Google Scholar 

Download references

Funding

This work was supported by the Health Commission of Hubei Province (WJ2019Q002) and the Science and Technology Department of Hubei Province (2019CFC892).

Author information

Authors and Affiliations

  1. Ultrasonography Department, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430030, China

    Huan Zhou, Manli Fu & Li Yuan

  2. Neurology Department, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430030, China

    Bing Mao

Authors
  1. Huan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manli Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bing Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Li Yuan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, H., Fu, M., Mao, B. et al. Cardiac Phenotype–Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review. Pediatr Cardiol 42, 189–198 (2021). https://doi.org/10.1007/s00246-020-02470-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-020-02470-4

Keywords

Search

Navigation